The role of necroptosis in cancer: A double-edged sword?

Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):259-266. doi: 10.1016/j.bbcan.2019.01.006. Epub 2019 Feb 1.

Abstract

Necroptosis is a programmed, caspase-independent cell death that is morphologically similar to necrosis. Unlike apoptosis, necroptosis evokes inflammatory responses by releasing damage-associated molecular patterns. Recent studies suggest that tumor undergoes necroptosis in vivo and necroptosis has pro- or anti-tumoral effects in cancer development and progression. Furthermore, triggering necroptosis in tumor cells has been explored as a potential therapeutic strategy against cancer. Here, we will review the recent research progress of necroptosis in conferring anti- or pro-tumoral effects and its potential application in cancer therapy.

Keywords: Cancer; MLKL; Metastasis; Necroptosis; RIPK3.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Cell Death / physiology*
  • Humans
  • Necrosis / pathology
  • Neoplasms / pathology*